Patients who received adjuvant chemotherapy and had high NOTCH1 mRNA expression in the tumour (n = 86) were three times more likely to have an RFI event (adjusted hazard ratio 3.1, 95% CI 1.321–7.245, p = 0.009). This evidence concerns the gene NOTCH1 and neoplasm.